Correlation Between CRISPR Therapeutics and Banco Bradesco

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Banco Bradesco at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Banco Bradesco into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and Banco Bradesco SA, you can compare the effects of market volatilities on CRISPR Therapeutics and Banco Bradesco and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Banco Bradesco. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Banco Bradesco.

Diversification Opportunities for CRISPR Therapeutics and Banco Bradesco

-0.06

Correlation Coefficient

CRISPR Therapeutics  Banco Bradesco

Good diversification

The 3 months correlation between CRISPR and Banco is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Banco Bradesco SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Banco Bradesco SA and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Banco Bradesco. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Banco Bradesco SA has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Banco Bradesco go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Banco Bradesco

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to under-perform the Banco Bradesco. In addition to that, CRISPR Therapeutics is 2.35 times more volatile than Banco Bradesco SA. It trades about -0.01 of its total potential returns per unit of risk. Banco Bradesco SA is currently generating about 0.1 per unit of volatility. If you would invest  1,041  in Banco Bradesco SA on December 24, 2024 and sell it today you would earn a total of  95.00  from holding Banco Bradesco SA or generate 9.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  Banco Bradesco SA

CRISPR Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, CRISPR Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Banco Bradesco SA

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Banco Bradesco SA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Banco Bradesco may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with CRISPR Therapeutics and Banco Bradesco

The main advantage of trading using opposite CRISPR Therapeutics and Banco Bradesco positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Banco Bradesco can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Banco Bradesco will offset losses from the drop in Banco Bradesco's long position.

The idea behind CRISPR Therapeutics AG and Banco Bradesco SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.